Show simple item record

FieldValueLanguage
dc.contributor.authorBlack, Harrison
dc.contributor.authorXu, Wenbo
dc.contributor.authorHortle, Elinor
dc.contributor.authorRobertson, Sonia
dc.contributor.authorBritton, Warwick
dc.contributor.authorKaur, Amandeep
dc.contributor.authorNew, Elizabeth
dc.contributor.authorWitting, Paul
dc.contributor.authorChami, Belal
dc.contributor.authorOehlers, Stefan
dc.date.accessioned2020-02-12
dc.date.available2020-02-12
dc.date.issued2019-05-01
dc.identifier.citationBlack, H. D., Xu, W., Hortle, E., Robertson, S. I., Britton, W. J., Kaur, A., … Oehlers, S. H. (2019). The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets. Free Radical Biology and Medicine, 135, 157–166. https://doi.org/10.1016/j.freeradbiomed.2019.03.010en
dc.identifier.urihttps://hdl.handle.net/2123/21834
dc.description.abstractTuberculosis is a chronic inflammatory disease caused by persistent infection with Mycobacterium tuberculosis. The rise of antibiotic resistant strains necessitates the design of novel treatments. Recent evidence shows that not only is M. tuberculosis highly resistant to oxidative killing, it also co-opts host oxidant production to induce phagocyte death facilitating bacterial dissemination. We have targeted this redox environment with the cyclic nitroxide derivative 4-methoxy-TEMPO (MetT) in the zebrafish-M. marinum infection model. MetT inhibited the production of mitochondrial ROS and decreased infection-induced cell death to aid containment of infection. We identify a second mechanism of action whereby stress conditions, including hypoxia, found in the infection microenvironment appear to sensitise M. marinum to killing by MetT both in vitro and in vivo. Together, our study demonstrates MetT inhibited the growth and dissemination of M. marinum through host and bacterial targets.en
dc.description.sponsorshipThis work was supported by the Australian National Health and Medical Research Council grants APP1099912 and APP1053407; The University of Sydney, Australia Fellowship G197581; NSW Ministry of Health, Australia under the NSW Health Early-Mid Career Fellowships Scheme H18/31086; and the Kenyon Family Inflammation Award (S.H.O.).en
dc.language.isoenen
dc.publisherElsevieren
dc.relationNHMRC APP1053407 and APP1099912en
dc.rightsOther
dc.subjectAntioxidanten
dc.subjectCell deathen
dc.subjectHost-directed therapyen
dc.subjectHypoxiaen
dc.subjectInfectionen
dc.subjectMitochondriaen
dc.subjectZebrafishen
dc.titleThe cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targetsen
dc.typeArticleen
dc.subject.asrcFoR::110707 - Innate Immunityen
dc.subject.asrcFoR::110801 - Medical Bacteriologyen
dc.identifier.doi10.1016/j.freeradbiomed.2019.03.010
dc.type.pubtypeAuthor accepted manuscripten
usyd.facultyFaculty of Medicine and Health, Sydney Medical Schoolen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.